Prognostic impact of EGFR/ALK alterations in leptomeningeal metastasis from lung adenocarcinoma treated with whole-brain radiotherapy-Reference-Cited by-同舟云学术

Prognostic impact of EGFR/ALK alterations in leptomeningeal metastasis from lung adenocarcinoma treated with whole-brain radiotherapy

Published:2023-07-19 Issue:5 Volume:40 Page:407-413
ISSN:0262-0898
Container-title:Clinical & Experimental Metastasis
language:en
Short-container-title:Clin Exp Metastasis

Author:

Oyoshi Hidekazu,Hirata Hidenari,Hirano Yasuhiro,Zenda Sadamoto,Zhou Yuzheng,Tomizawa Kento,Fujisawa Takeshi,Nakamura Masaki,Hojo Hidehiro,Motegi Atsushi,Kageyama Shun-Ichiro,Zenke Yoshitaka,Goto Koichi,Ishihara Shunichi,Naganawa Shinji,Akimoto Tetsuo

Funder

The Yasuda Medical Foundation

The National Cancer Center Research and Development Fund

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10585-023-10225-7.pdf

Reference17 articles.

1. Remon J, Le Rhun E, Besse B (2017) Leptomeningeal carcinomatosis in non-small cell lung cancer patients: a continuing challenge in the personalized treatment era. Cancer Treat Rev 53:128–137

2. Alexander M, Lin E, Cheng H (2020) Leptomeningeal metastases in non-small cell lung cancer: optimal systemic management in NSCLC with and without driver mutations. Curr Treat Options Oncol 21(9):1–15

3. Cheng H, Perez-Soler R (2018) Leptomeningeal metastases in non-small-cell lung cancer. Lancet Oncol 19(1):e43–e55

4. Network NCC (n.d.) Central nervous system cancers (version 2.2021). https://www.nccn.org/professionals/physician_gls/pdf/cns.pdf. Accessed 9 Aug 2022

5. Yan W, Liu Y, Li J, Han A, Kong L, Yu J et al (2019) Whole brain radiation therapy does not improve the overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastasis. Radiat Oncol 14(1):1–10